Even though a large proportion of cancer patients carry genetic mutations that make them more susceptible to cancer, only a ...

The surge in genomics and proteomics research for disease diagnosis, drug discovery, and personalized medicine is a primary driver of the DNA microarray market. Applications in Disease Diagnostics: ...

Dublin, June 30, 2025 (GLOBE NEWSWIRE) -- The "Chromosomal Microarray Market Size, Share, Trends, Analysis, and Forecast 2025-2034 | Global Industry Growth, Competitive Landscape, Opportunities, and ...

Each month, The Clinical Advisor makes one new clinical feature available ahead of print. Don’t forget to take the poll. The results will be published in the next month’s issue. Healthcare providers ...

Over the next five years, up to 100,000 people in Ontario will be screened for genetic conditions that increase their risk of hereditary cancers and a condition tied to high cholesterol and heart ...

Reportlinker.com announces that a new market research report is available in its catalogue: Microarray Marketshttp://www.reportlinker.com/p096372/Microarray-Markets ...

Genetic factors significantly influence breast cancer risk, with up to 10% of cases being hereditary. Key risk factors include family history, genetic mutations such as BRCA1/BRCA2, and polygenic risk ...

Jill Martin is taking a cause close to her heart to "Football Night in America." Ahead of the Bengals-Giants game on Sunday, Oct. 13, Jill joined the program to discuss her history with breast cancer ...